Pinklap Pharmaceuticals Private Limited
About Pinklap Pharmaceuticals Private Limited
Data last updated:
Pinklap Pharmaceuticals Private Limited is a private limited company based in Thane, Maharashtra, India. It operates in the healthcare services segment of the healthcare sector. It was incorporated on 23 March 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U85100MH2018PTC307018. The company has 1 GST registration on record, which is no longer active.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Satyam Ramprasad Singh (Managing Director) and Rananjay Singh.
Its last annual general meeting (AGM) was held on 31 December 2020, and its latest financial statements are for the year ended 31 March 2020. The registered office is at Building No.100 Flat No.104 Samrudhhi Evergreen Kalyan Karjat Road, Thane, Maharashtra, India – 421503.
As per the financials filed for FY 2020, the company reported a revenue of ₹12.9 Lakh. For the same year it recorded a net loss of ₹30,640 (net margin -2.4%) and EBITDA of -₹30,640 (EBITDA margin -2.4%).
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressBuilding No.100 Flat No.104 Samrudhhi Evergreen Kalyan Karjat Road, Thane, Maharashtra, India – 421503
- IndustryHealthcare, Human Health Activities
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Pinklap Pharmaceuticals Private Limited
The main business activity of Pinklap Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Pinklap Pharmaceuticals Private Limited FY 2020 filings available
Pinklap Pharmaceuticals Private Limited reported revenue of ₹12.9 Lakh for FY 2020.
Financial Statement Summary of Pinklap Pharmaceuticals Private Limited
| Metrics | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | ₹12.9 Lakh | •••• | •••• |
| Other Income | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• |
| EBITDA | -₹30,640 | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• |
| Net Profit (PAT) | -₹30,640 | •••• | •••• |
| Balance Sheet | |||
| Share Capital | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• |
Financial Ratios of Pinklap Pharmaceuticals Private Limited
| Metrics | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | -2.4% | •••• | •••• |
| Net Profit Margin | -2.4% | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• |
| Liquidity and Debt | |||
| Current Ratio | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• |
| Efficiency and Growth | |||
| Asset Turnover | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Pinklap Pharmaceuticals are in the company report.
Financial statements from FY 2018
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Pinklap Pharmaceuticals Private Limited
Pinklap Pharmaceuticals Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Pharmaceuticals). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Devi Pharmaceuticals Private Limited | ₹12.97 Lakh (FY 2024) | •••• | •••• | 75.0% | •••• | Ernakulam, Kerala, India |
| Sporelin Pharmaceuticals Private Limited | ₹12.95 Lakh (FY 2019) | •••• | •••• | -38.0% | •••• | Aurangabad, Maharashtra, India |
| Aavn Pharmaceuticals (OPC) Private Limited | ₹12.92 Lakh (FY 2025) | •••• | •••• | -18.0% | •••• | Secunderabad, Telangana, India |
| Valmicare Pharmaceuticals Private Limited | ₹12.91 Lakh (FY 2019) | •••• | •••• | -54.0% | •••• | Hyderabad, Telangana, India |
| MGD Pharmaceuticals Private Limited | ₹12.91 Lakh (FY 2024) | •••• | •••• | 690.0% | •••• | Thane, Maharashtra, India |
| Pinklap Pharmaceuticals Private Limited this company | ₹12.9 Lakh (FY 2020) | •••• | •••• | •••• | Thane, Maharashtra, India | |
| Sukem Pharmaceuticals Private Limited | ₹12.9 Lakh (FY 2025) | •••• | •••• | 7.0% | •••• | New Delhi, Delhi, India |
| Dwaraka Ayurvedic Pharmaceuticals (P) Ltd | ₹12.89 Lakh (FY 2025) | •••• | •••• | -17.0% | •••• | Palghat, Kerala, India |
| Shreeshiddivinayak Pharmaceuticals Private Limited | ₹12.89 Lakh (FY 2022) | •••• | •••• | 615.0% | •••• | Gwalior, Madhya Pradesh, India |
| Stile Pharmaceuticals Private Limited | ₹12.88 Lakh (FY 2024) | •••• | •••• | -9.0% | •••• | Thane, Maharashtra, India |
| D Cross Pharmaceuticals Private Limited | ₹12.86 Lakh (FY 2025) | •••• | •••• | 34.0% | •••• | Delhi, India |
Peers are the five companies nearest above and the five nearest below Pinklap Pharmaceuticals by revenue in the Pharma industry (Pharmaceuticals), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Board of Directors of Pinklap Pharmaceuticals Private Limited
Pinklap Pharmaceuticals has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rananjay Singh | Director | 23 Jun 2023 | 3 Years 3 Months | Current |
| Satyam Ramprasad Singh | Managing Director | 23 Mar 2018 | 8 Years 6 Months | Current |
Ownership and Shareholding of Pinklap Pharmaceuticals Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Pinklap Pharmaceuticals Private Limited
Pinklap Pharmaceuticals Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Pinklap Pharmaceuticals Private Limited
Employment history and EPFO contributions of people linked to Pinklap Pharmaceuticals.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Pinklap Pharmaceuticals Private Limited
Pinklap Pharmaceuticals Private Limited has 3 board changes on record since 2018: 2 appointments and 1 cessation. The latest: Durgesh Singh ceased to be Director on 07 Jul 2023.
Credit Ratings, Litigation & Regulatory Alerts for Pinklap Pharmaceuticals Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Pinklap Pharmaceuticals Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Pinklap Pharmaceuticals Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Pinklap Pharmaceuticals Private Limited
Pinklap Pharmaceuticals has 1 GST registration on record, and it has been cancelled or is inactive. Only active GST numbers are listed on this page.
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Pinklap Pharmaceuticals Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Pinklap Pharmaceuticals Private Limited
Pinklap Pharmaceuticals is an active private limited company based in Thane, Maharashtra, India. The company works in human health activities, within the healthcare industry. It was incorporated on 23 March 2018 (8+ years old) and is registered under CIN U85100MH2018PTC307018.
Pinklap Pharmaceuticals reported revenue of ₹12.9 Lakh for FY 2020.
Pinklap Pharmaceuticals has 2 current directors:
- Satyam Ramprasad Singh - Managing Director
- Rananjay Singh - Director
Pinklap Pharmaceuticals reported a net loss of ₹30,640 (net margin -2.4%) and EBITDA of -₹30,640 (EBITDA margin -2.4%) for FY 2020, as per its filed financial statements.
No. Pinklap Pharmaceuticals has 1 GST registration on record and it is cancelled or inactive.
The CIN (Corporate Identification Number) of Pinklap Pharmaceuticals is U85100MH2018PTC307018. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Pinklap Pharmaceuticals was incorporated on 23 March 2018, making it 8+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Pinklap Pharmaceuticals by revenue are Devi Pharmaceuticals Private Limited, Sporelin Pharmaceuticals Private Limited, Aavn Pharmaceuticals (OPC) Private Limited, Valmicare Pharmaceuticals Private Limited, MGD Pharmaceuticals Private Limited and 5 more, all in the Pharma industry (Pharmaceuticals).
Durgesh Singh ceased to be Director on 07 Jul 2023. Rananjay Singh was appointed as Director on 23 Jun 2023. Satyam Ramprasad Singh was appointed as Managing Director on 23 Mar 2018.
The registered office of Pinklap Pharmaceuticals is at Building No.100 Flat No.104 Samrudhhi Evergreen Kalyan Karjat Road, Thane, Maharashtra, India – 421503.
Pinklap Pharmaceuticals has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh.